(PDF) Pnd96 - Four-Year Resource Use and Costs Associated

Pnd96 - Four-Year Resource Use and Costs Associated With Administration and Monitoring of Disease Modifying Drugs in Patients With Multiple Sclerosis

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.2062

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

The Association of Adherence to Disease-Modifying Drugs and Out-Of-Pocket Costs in Patients With Multiple Sclerosis

Value in Health

Occupational Health

English

Persistence With Biological Disease-Modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs

Drugs - Real World Outcomes

English

Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis

Value in Health

Occupational Health

English

Infections in Patients With Multiple Sclerosis: Implications for Disease-Modifying Therapy

Acta Neurologica Scandinavica

English

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics

Archives of Neurology

English

Healthcare Costs and Resource Utilization in Patients With Multiple Sclerosis Relapses Treated With H.P. Acthar Gel®

Advances in Therapy

English

Characteristics of Pediatric Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

Value in Health

Occupational Health

English

Multiple Sclerosis Disease-Modifying Therapy and Pregnancy

Multiple Sclerosis

English

Pnd40 - Cost of Healthcare Resource Use by Patients With Multiple Sclerosis in France According to Disease Severity

Value in Health

Occupational Health

English